Inflammasome Therapeutics, Inc.

Biotechnology company · Newton, Massachusetts, United States

Inflammasome Therapeutics, Inc. is a biotechnology company headquartered in Newton, Massachusetts, United States. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Inflammasome Therapeutics at a glance

Typebiotechnology company

HeadquartersNewton, Massachusetts, United States

SEC CIK1989925

What does Inflammasome Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $13.2 million sold (2026).

Frequently asked questions about Inflammasome Therapeutics

Where is Inflammasome Therapeutics headquartered?

Inflammasome Therapeutics, Inc. is headquartered in Newton, Massachusetts, United States.

What does Inflammasome Therapeutics do?

Inflammasome Therapeutics, Inc. is a biotechnology company.

Similar companies

Lumicell, Inc.Newton, Massachusetts, United States
Acumen Pharmaceuticals, Inc.Newton, Massachusetts, United States
Courage Therapeutics, Inc.Newton, Massachusetts, United States
Extend Biosciences IncNewton, Massachusetts, United States
Normatec Industries, LPNewton, Massachusetts, United States
TheraNano LLCNewton, Massachusetts, United States
Auron Therapeutics, Inc.Newton, Massachusetts, United States
Diceros Therapeutics, Inc.Newton, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences